Thank you for considering this survey.

Since the discontinuation of Nolvadex and the aromatase inhibitors coming of patent, there are a plethora of generic preparations available to treat oestrogen sensitive breast cancer. We would be grateful if you could complete this short survey on your experience of generic prescriptions of tamoxifen, letrozole, anastrazole and exemestane. Siobhan Laws & Bashar Zeidan Consultant Surgeon and SpR at Hampshire Hosptial NHS Trust Breast Unit. siobhan.laws@hhft.nhs.ukĀ 

T